"Following the review of the data of the 101 trial, the drug advanced to the Phase II 201 trial (NCT05424276). This is a 12-week, randomized, double-blind, multi-center, placebo-controlled, dose-ranging clinical trial of three IkT 148009 doses in patients with untreated Parkinson's disease."
------------------------------------
pretty encouraging video presentation. Good thing to keep an eye on. Thanks, JG
I thought that the trial had had to stop due to an fda hold notice
do you have a link for that? cause i can't find anything
Take a look at my posts.
thanks! and that's a real 'RED FLAG' isn't it? bummer
Why doesn't the article tell you why the hold was placed? I looked up reasons for holds on clinical trials. The article discusses possible reasons a trial could be put on hold:
fda.gov/drugs/investigation...
good point! good research! good post!
Inhibikase says that no adverse effects have been observed in past research so since they are supposed to supply a letter to the company within 30 days of the reason they have put the study on hold it seems like that should be available around Dec 7th
good post, thanks!
3 current disease modifying stage 3 trials studies. But lactobacillus acidophilus ?
Phase 2 Mesenchymal Stem Cell Trial in USA
Promising disease modifying therapies for PDExenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (Exenatide-PD3)Nicotinamide riboside supplement shows promise as a potential therapy for Parkinson’s disease - I started taking it today!
